---
category: news
title: "Avenda Health Granted FDA Breakthrough Device Designation for Technology to Treat Prostate Cancer"
excerpt: "Breakthrough Device Designation was awarded to Avenda Health for a male “lumpectomy” product in development designed to treat prostate cancer in-office while preserving quality of life. Breakthrough Device Designation by FDA is reserved for devices that are potentially transformative,"
publishedDateTime: 2021-05-11T16:00:00Z
originalUrl: "https://www.businesswire.com/news/home/20210511005137/en/Avenda-Health-Granted-FDA-Breakthrough-Device-Designation-for-Technology-to-Treat-Prostate-Cancer"
webUrl: "https://www.businesswire.com/news/home/20210511005137/en/Avenda-Health-Granted-FDA-Breakthrough-Device-Designation-for-Technology-to-Treat-Prostate-Cancer"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "FDA Grants Breakthrough Device Designation to Lumpectomy Product in Prostate Cancer"
    excerpt: "The FDA has granted a breakthrough device designation to the Avenda Health Focal Therapy System, a male “lumpectomy” product under development to treat patients with prostate cancer in office while preserving quality of life."
    publishedDateTime: 2021-05-11T20:10:00Z
    webUrl: "https://www.onclive.com/view/fda-grants-breakthrough-device-designation-to-lumpectomy-product-in-prostate-cancer"
    type: article
    provider:
      name: OncLive.com
      domain: onclive.com
    quality: 0

secured: "gnSZCVkaCJ8leTPa18WzB0YhlAwi6Y8qTByv4/WJSjGUqdFG1wvfNTkVo5BDNHmo5mvxr+iBCu29J0wRZjnYLBKKwFNaUgruJn1E3Qi0hcASTiTIvR7azw78hhZpbrRZrrTXUB99G/IHCbKD4FrYXxOntNT6/COUeA2UaSRFEdAGhZUVKWlB3pz2vc3KX6a1wbTTPTjXRmGbAa/fTPJ/Zf7PMjA4v+ljiTCnzG4JLsozdCWI/PYlLKtvFBkgAlWGW6Y1jJUBWk+MVadJ/Hi/HH0cnQ8k2McMYbZcSgkNoqsFmlQFX95muRlXP7p22Vt+TFXJExBnbHxtX1bBUGjWx46oihElIfMDJf/FBjI8S98=;EUBye8+aJoM0WNwdrRY15A=="
---

